期刊文献+

重组Pegfp-C2-PSF质粒的构建及表达 被引量:1

Construction and Expression of pEGFP-C2-PSF Recombinant Plasmid
原文传递
导出
摘要 目的将人类PSF基因定向连人pEGFP-C2质粒,使PSF蛋白可与绿色荧光蛋白在HeLa细胞内融合表达,为进一步研究PSF蛋白的功能及定位奠定实验基础。方法采用EcoR I和Sal I双酶切方法,从pGEX-2TK-PSF质粒中获得PSF蛋白的cDNA全长;连入pEGFP-C2质粒的C端。将构建成功的pEGFP-C2-PSF质粒转染人HeLa细胞,荧光显微镜下观察绿色荧光蛋白表达。结果①将该质粒进行双酶切鉴定可见PSF片段;②转染重组质粒后可观察到绿色荧光蛋白的表达。结论①PSFcDNA全长成功连入pEG-FP-C2质粒;②PSF蛋白可与绿色荧光蛋白在HeLa细胞中融合表达。 Objective To construct eukaryotic green fluorescent protein (GFP) expressing recombinant plasmids, pEGFP-C2-PSF, which contains human PSF full length cDNA. Methods The PSF full length cDNA was obtained from EcoR I/Sal I digested pGEX-2TK-PSF plasmid, and inserted into pEGFP-C2 fluorescent expressing vector. This recombinant pEGFP-C2-PSF plasmid was transfected into HeLa cell line and the expression of green fluorescent fusion protein was observed by fluorescence microscopy. Results (1) The PSE fragment was seen after double digestion of pEGFP-C2-PSF. (2) The expression of green fluorescent fusion protein was detected in the HeLa cells transfected with recombinant pEGFP-C2-PSF. Conclusion The full length of PSF cD- NA fragment was correctly inserted into the pEGFP-C2 vector. The fluorescent expressing recombinant plasmids pEGFP-C2-PSF expressed PSF-GFP fusion proteins successfully.
出处 《医学分子生物学杂志》 CAS CSCD 2009年第3期235-238,共4页 Journal of Medical Molecular Biology
基金 国家高技术研究发展计划(863计划)(No.2007AA02Z115),国家自然科学基金(No.30670441,30300070),国家教育部新世纪人才支持计划(No.NCET-04-0245),天津市科委应用基础研究重点项目(No.07JCZDJC07300),天津市科委国际合作项目(No.05YFGHHZ01300)
关键词 人类PSF蛋白 PEGFP-C2 重组质粒 融合蛋白 Human PSF protein pEGFP-C2 Recombinant plasmid Fusion protein
  • 相关文献

参考文献10

  • 1EMILI A, SHALES M, MCCRACKEN S, et al. Splicing and transcription-associated proteins PSF andp54nrb/nono bino to RNA polymerase II CTD[J]. RNA, 2002, 8(9) :1102-1111.
  • 2URBAN R J, BODENBURG Y H, WOOD T G. NH2 terminus of PTB-associated splicing factor binds to the porcine P450scc IGF-I response element[ J]. Am J Physiol Endocrinol Metab, 2002, 283 (3) : 423-427.
  • 3BLADEN C L, UDAYAKUMAR D, TAKEDA Y, et al. Identification of the polypyrimidine tract binding protein-associated splicing factor, p54 (nrb) complex as a candidate DNA double-strandbreak rejoining factor[J]. J Biol Chem, 2005, 280(7) : 5205- 5210.
  • 4PENG R, DYE B T, PEREZ I, et al. PSF and p54nrb bind a conserved stem in U5 snRNA[J]. RNA, 2002, 8(10) : 1334- 1347.
  • 5ROSONINA E, IP J Y, CALARCO J A, et al. Role for PSF in mediating transcriptional activator-dependent stimulation of premRNA processing in vivo [ J ] . Mol Cell Biol. 2005, 5 ( 15 ) : 6734-6746.
  • 6LUTZ C S, COOKE C, O'CONNR J P, et al. The snRNP-free U1A (SF-A) complex(es) : identification of the largest subunit as PSF, the polypyrimidine-tract binding protein-associated splicing factor[J]. RNA, 1998, 4(12): 1493-1499.
  • 7SONG X, SUN Y, GAREN A. Roles of PSF protein and VL30 RNA in reversible gene regulation[J]. Proc Natl Aead Sei USA, 2005, 102(34): 12189-12193.
  • 8URBAN R J, BODENBURG Y. PTB-associated splicing factor regulates growth factor-stimulated gene expression in mammalian ceils [ J ]. Am J Physiol Endocrinol Metab, 2002, 283 (4) : 794- 798.
  • 9MATHUR M, TUCKER P W, SSMUELS H H. PSF is a novel compressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors [ J]. Mol Cell Biol, 2001,21(7) : 2298-2311.
  • 10URBAN R J, BODENBURG Y, KUROSKY A. Polypyrimidine tract-associated splicing factor is a negative regulator of transcriptional activity of the porcine p450scc insulin-like growth factor response element [ J ]. Mol Endocrinol, 2000,14 ( 6 ) :774 -782.

同被引文献20

  • 1Deissler HL, Deissler H, Lang GE, et al. Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial ceils [ J ]. Br J Ophthalmol, 2011,95 ( 8 ) : 1151 - 1156. DOI: 10.1136/bjo. 2010. 192229.
  • 2Nicosia RF, Nicosia SV, Smith M, et al. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro[ J ]. Am J Pathol, 1994,145 (5) : 1023-1029.
  • 3Chantelau E,Meyer-Schwickerath R,et al. Reversion of "early worsening" of diabetic retinopathy by deliberate restoration of poor metabolic control [ J]. Ophthalmologica, 2003,217 (5) : 373 - 377. DOI: 10. 1159/ 000071355.
  • 4Urban RJ, Bodenburg YH, Wood TG, et al. NH2 terminus of PTB- associated splicing factor binds to the porcine P450scc IGF-I response element[ J ]. Am J Physiol Endocrinol Metab,2002,283 (3) :423-427. DOI : 10. 1152/ajpendo. 00057. 2002.
  • 5Urban RJ,Bodenburg Y, Kurosky A, et al. Polypyrimidine tract-binding protein-associated splicing factor is a negative regulator of transcriptional activity of the porcine p450scc insulin-like growth factor response element[ J ]. Mol Endocrino1,2000,14 ( 6 ) : 774-782.
  • 6Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor[ J]. Endocr Rev, 1997,18 ( 1 ) : 4-25.
  • 7Punglia RS, Lu M, Hsu J, et al. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I [J]. Diabetes, 1997,46 ( 10 ) : 1619-1626. DOI : 10. 2337/diacare. 46.10. 1619.
  • 8Danis RP, Bingaman DP. Insulin-like growth factor-1 retinal microangiopathy in the pig eye [ J]. Ophthalmology, 1997,104 ( 10 ) : 1661-1669.
  • 9Baudouin C, Fredj-Reygrobellet D, Brignole F, et al. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy [ J]. Ophthalmic Res, 1993,25 ( 1 ) : 52-59.
  • 10Merimee TJ,Zapf J,Froesch ER. Insulin-like growth factors. Studies in diabetics with and without retinopathy[J]. N Engl J Med, 1983,309 (9) : 527-530. DOI:10. 1056/NEJM198309013090904.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部